검색
Protalix Biotherapeutics Inc
PLX관심 목록에 추가
2.395USD
+0.025+1.05%
종가 07-27 16:00（ET）시세는 15분 지연됩니다
192.97M시가총액
12.40P/E TTM
자세한 내용은 Protalix Biotherapeutics Inc 회사
Protalix BioTherapeutics, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of recombinant therapeutic proteins expressed through its proprietary plant cell-based expression system, ProCellEx. In addition, the Company is developing PEGylated uricase, or PRX-115, for the treatment of uncontrolled gout, Long Acting (LA) DNase I, or PRX-119, for the treatment of NETs-related diseases, and other technologies and preclinical assets. Its ProCellEx platform is being used to manufacture both of its approved and marketed products as well as PRX-115 and PRX-119. PRX-115, a plant cell-expressed recombinant PEGylated Uricase (urate oxidase) - a chemically modified enzyme to treat uncontrolled gout. PRX-119 is a plant cell-expressed PEGylated recombinant human DNase I product candidate. Its product includes Elelyso and Elfabrio. Elelyso is an enzyme replacement therapy (ERT) for the treatment of patients with Gaucher disease.
Protalix Biotherapeutics Inc 정보
종목 코드 PLX
회사 이름Protalix Biotherapeutics Inc
상장일Sep 06, 2010
CEOBashan (Dror)
직원 수207
유형Ordinary Share
회계 연도 종료Sep 06
주소2 University Plaza
도시HACKENSACK
증권 거래소NASDAQ OMX – NASDAQ Basic Amex
국가United States of America
우편 번호07601
전화12016969345
웹사이트https://protalix.com/
종목 코드 PLX
상장일Sep 06, 2010
CEOBashan (Dror)
Protalix Biotherapeutics Inc의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Mr. Dror Bashan
Mr. Dror Bashan
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.53M
+7.70%
Dr. Aharon Schwartz, Ph.D.
Dr. Aharon Schwartz, Ph.D.
Independent Director
Independent Director
310.50K
+2.42%
Mr. Yaron Naos
Mr. Yaron Naos
Senior Vice President - Operations
Senior Vice President - Operations
232.30K
+10.76%
Dr. Pol F. Boudes, M.D.
Dr. Pol F. Boudes, M.D.
Independent Director
Independent Director
7.54K
+99.47%
Ms. Gwen A. Melincoff
Ms. Gwen A. Melincoff
Independent Director
Independent Director
7.50K
+99.47%
Mr. Gilad Mamlok
Mr. Gilad Mamlok
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
3.63K
--
Mr. Amos Bar Shalev
Mr. Amos Bar Shalev
Independent Director
Independent Director
--
--
Dr. Shmuel (Muli) Ben-Zvi, Ph.D.
Dr. Shmuel (Muli) Ben-Zvi, Ph.D.
Independent Director
Independent Director
--
--
Dr. Eliot Richard Forster, Ph.D.
Dr. Eliot Richard Forster, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Mike Moyer
Mr. Mike Moyer
Investor Relations
Investor Relations
--
--
이름
이름/직위
직위
주식 보유
변동
Mr. Dror Bashan
Mr. Dror Bashan
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.53M
+7.70%
Dr. Aharon Schwartz, Ph.D.
Dr. Aharon Schwartz, Ph.D.
Independent Director
Independent Director
310.50K
+2.42%
Mr. Yaron Naos
Mr. Yaron Naos
Senior Vice President - Operations
Senior Vice President - Operations
232.30K
+10.76%
Dr. Pol F. Boudes, M.D.
Dr. Pol F. Boudes, M.D.
Independent Director
Independent Director
7.54K
+99.47%
Ms. Gwen A. Melincoff
Ms. Gwen A. Melincoff
Independent Director
Independent Director
7.50K
+99.47%
Mr. Gilad Mamlok
Mr. Gilad Mamlok
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
3.63K
--
자주 묻는 질문
Protalix Biotherapeutics Inc의 상위 5대 주주는 누구인가요?
Protalix Biotherapeutics Inc의 상위 5대 주주는 다음과 같습니다: Mr. Dror Bashan
Protalix Biotherapeutics Inc(PLX)의 주식을 보유한 기관은 몇 개입니까?
2026Q1 기준으로, Protalix Biotherapeutics Inc의 주식을 보유한 기관은 총 193곳이며, 이들이 보유한 주식의 총 가치는 약 19.91M로 전체 발행 주식의 24.71%를 차지합니다. 이는 2025Q4 대비 2149424.00 증가한 수치입니다.